## Abstract ## BACKGROUND Hepatitis B virus (HBV) infection is a common disease in China. Severe hepatitis is a well recognized complication in HBV carriers with malignant disease who receive cytotoxic chemotherapy. The objective of the current study was to assess the value of antiviral lamivudine
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy
β Scribed by Yu Xuan Koo; Daniel S. W. Tan; Iain B. Tan; Miriam Tao; Wan Cheng Chow; Soon Thye Lim
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 143 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Over a seven-year period, we monitored 221 patients with chronic hepatitis from two medical centers. By using the counterlectrophoresis (CEP) test to detect the presence of HBsAg and anti-HBc, or both, we established that 87.7% of them had hepatitis B infection. Serum specimens originally found nega
## Abstract ## Objective To characterize the clinical and immunologic patterns of expression, response to therapy, and outcome of patients with SjΓΆgren's syndrome (SS) and associated hepatitis C virus (HCV) infection who developed B cell lymphoma. ## Methods Various international reference cente
## Abstract This study assessed the association of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection with nonβHodgkin's lymphoma in a highly HBVβendemic area. The prevalence of either HBV or HCV infection in 235 patients with nonβHodgkin's lymphoma was compared with that of an ageβ and
Several lines of evidence have suggested that immune mechanisms are involved in the pathogenesis of hepatitis B virus (HBV)-and hepatitis C virus (HCV)-related hepatitis. Study of patients with dual HBV and HCV infection raises the question of which is etiologically more relevant in determining the